Nanotechnology Now

Our NanoNews Digest Sponsors

Heifer International

Wikipedia Affiliate Button

Home > Press > National Dendrimer and Nano Center Attracts Emerging Bio Lab

CMU National Dendrimer and Nanotechnology Center Attracts Emerging Biotechnology Laboratory

Posted on January 06, 2006

A company developing biotechnologies for coatings and artificial cells that may treat many health conditions is locating a laboratory at Central Michigan University.

Initially, two researchers from Connecticut-based Artificial Cell Technologies Inc. will be located in CMU's Dow Science Complex. One ACT staff person has been at CMU since last summer.

In the future, ACT will join Dendritic NanoTechnologies Inc. and MultiGEN Diagnostics Inc. in relocating to a $5 million CMU wet lab facility that is supported by a $2.15 million U.S. Department of Commerce grant, $250,000 in Michigan Economic Development Corp. funding and $2.6 million from CMU.

The company is commercializing a new nanotechnology involving designed polypeptides that may lead to treatments for many health conditions and opportunities for research for CMU faculty and students.

Using technology originally developed at Louisiana Tech University, ACT designs, characterizes and produces complex, multilayer, nano-assembled polypeptide films, coatings and microcapsules. Peptides are natural or synthetic compounds containing two or more amino acids. Polypeptides are small proteins typically containing between 10 and 100 molecules of amino acids.

Among ACT's current research and development priorities are enantioselective filter membranes for pharmaceutical research and manufacturing, coatings for cell and tissue culture, and the encapsulation of hemoglobin to make artificial red blood cells. A safe, universally transfusible artificial red blood cell with a long life span in the body would transform human health, potentially eliminating blood supply shortages while also representing a new treatment modality for chronic conditions such as congestive heart disease, microvasculature disease and long-lasting anemias such as those caused by malaria.

ACT's technology also appears well suited to development of microcapsules for systemic or targeted drug delivery with tunable timed-release and other useful medical properties, multiantigen artificial virus vaccines, biocompatible coatings for medical devices and instruments, and antimicrobial coatings for food, food packaging or clothing.

ACT Chief Scientific Officer Don Haynie said that from the time of his first visit to CMU, he has been impressed with the capabilities of CMU's faculty and students, as well as the advanced equipment and facilities. The potential for synergistic relationships with other young technology firms at CMU's National Dendrimer and Nanotechnology Center, including Dendritic Nanotechnologies and Bio-ID Diagnostic, also appeals to Haynie.

"We are excited about the opportunity to be involved in bringing new educational opportunities to CMU while also leveraging the many scientific assets available within the central Michigan community to help ACT develop and commercialize our valuable products," said Haynie.

CMU students and faculty will have the opportunity to collaborate on projects and learn new skills through hands-on research experiences, including polypeptide synthesis and purification and the design and assembly of polypeptide nanostructures.

ACT Chief Executive Officer Tom Malone said, "The potential for achieving world-leading therapeutic and industrial advancements is greatly advanced by CMU's willingness to invest time, money and energy in fostering university-private company partnerships."

Malone also credited the support and vision of top officers at the university, valuable business services from the CMU Research Corp., and lower operating costs associated with research and development activities, when compared to the East Coast.

####
CMURC Contact:
Brent Case
(989) 774-1021
brent.case@cmich.edu

ACT Contact:
Thomas Malone
(203) 402-7209

Copyright Central Michigan University

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

Possible Futures

New exotic phenomena seen in photonic crystals: Researchers observe, for the first time, topological effects unique to an open system January 12th, 2018

'Decorated' stem cells could offer targeted heart repair January 11th, 2018

Nanotube fibers in a jiffy: Rice University lab makes short nanotube samples by hand to dramatically cut production time January 11th, 2018

STMicroelectronics Selects GLOBALFOUNDRIES 22FDX to Extend Its FD-SOI Platform and Technology Leadership : GFs FDX technology will enable ST to deliver high-performance, low-power products for next-generation consumer and industrial applications January 9th, 2018

Investments/IPO's/Splits

Nanometrics to Participate in the 6th Annual NYC Investor Summit 2017 November 16th, 2017

180 Degree Capital Corp. Leads Investment in TheStreet, Inc.; Investment Enables Removal of Capital Structure Overhang November 14th, 2017

Arrowhead Pharmaceuticals Reports Inducement Grants under NASDAQ Marketplace Rule 5635(c)(4) October 23rd, 2017

Arrowhead Hosts Investor & Analyst R&D Day to Introduce TRiM(TM) Platform and Lead RNAi-based Drug Candidates September 14th, 2017

Nanomedicine

'Decorated' stem cells could offer targeted heart repair January 11th, 2018

Rice University lab modifies nanoscale virus to deliver peptide drugs to cells, tissues January 8th, 2018

SNUH team develops new nanomaterial for thermal cancer therapy January 5th, 2018

Novel nanomedicine inhibits progression of pancreatic cancer in mice: Survival rates in pancreatic cancer linked to inverse correlation between specific oncogene and tumor suppressant, Tel Aviv University researchers say January 3rd, 2018

Materials/Metamaterials

Nanotube fibers in a jiffy: Rice University lab makes short nanotube samples by hand to dramatically cut production time January 11th, 2018

New oxide and semiconductor combination builds new device potential: Researchers integrated oxide two-dimensional electron gases with gallium arsenide and paved the way toward new opto-electrical devices January 10th, 2018

Ultrafine fibers have exceptional strength: New technique developed at MIT could produce strong, resilient nanofibers for many applications January 5th, 2018

NRL improves optical efficiency in nanophotonic devices January 4th, 2018

Announcements

New exotic phenomena seen in photonic crystals: Researchers observe, for the first time, topological effects unique to an open system January 12th, 2018

'Decorated' stem cells could offer targeted heart repair January 11th, 2018

Nanotube fibers in a jiffy: Rice University lab makes short nanotube samples by hand to dramatically cut production time January 11th, 2018

IBM Breaks Records to Top U.S. Patent List for 25th Consecutive Year: IBM Inventors Receive Record 9,043 Patents in 2017 in Areas such as Artificial Intelligence, Cloud, Blockchain, Cybersecurity and Quantum Computing January 11th, 2018

NanoNews-Digest
The latest news from around the world, FREE



  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoTech-Transfer
University Technology Transfer & Patents
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project